LAB. ROVI secures contract for 1637/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of R1100 - Risperidone [75 Mg/0383 Ml; Susp Powder Inj Lp; Syringe] And R1101 - Risperidone [100 Mg/0490 Ml; Susp Powder Inj Lp;

Posted On: 2025-07-18

Portugal, July 18 -- Portugal based LAB. ROVI has secured contract from Unidade Local De Saude Da Guarda, E.P.E for 1637/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of R1100 - Risperidone [75 Mg/0383 Ml; Susp Powder Inj Lp; Syringe] And R1101 - Risperidone [100 Mg/0490 Ml; Susp Powder Inj Lp;. The value of the contract is worth 4240570 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

LAB. ROVI secures contract for 1637/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of R1100 - Risperidone [75 Mg/0383 Ml; Susp Powder Inj Lp; Syringe] And R1101 - Risperidone [100 Mg/0490 Ml; Susp Powder Inj Lp;